Ancora Advisors’s Applied Therapeutics APLT Stock Holding History

Ancora Advisors’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,500	Closed	-$2K	–	2053
2022 Q2	$2K	Hold	2,500	–	–	﹤0.01%	1926
2022 Q1	$5K	Hold	2,500	–	–	﹤0.01%	1938
2021 Q4	$22K	Hold	2,500	–	–	﹤0.01%	1548
2021 Q3	$41K	Hold	2,500	–	–	﹤0.01%	1259
2021 Q2	$52K	Hold	2,500	–	–	﹤0.01%	1090
2021 Q1	$47K	Hold	2,500	–	–	﹤0.01%	1092
2020 Q4	$55K	Buy	+2,500	New	+$52.1K	﹤0.01%	856

Other funds holding APLT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Ancora Advisors's APLT Position: Q3 2022 in Review

Ancora Advisors sold out of Applied Therapeutics (APLT) in Q3 2022, closing a stake of 2,500 shares — an estimated $2K sold.

Ancora Advisors first reported a position in APLT in Q4 2020 and held it in 7 quarters. The position peaked at $55K in Q4 2020. 44 funds tracked by Wall St. Rank hold APLT as of Q3 2022.

Ancora Advisors reported no remaining Applied Therapeutics position as of Q3 2022 after selling out during the quarter.
Ancora Advisors sold 2,500 Applied Therapeutics shares in Q3 2022, an estimated $2K.
Ancora Advisors first reported a position in Applied Therapeutics in Q4 2020 and held it in 7 quarters.
Ancora Advisors's Applied Therapeutics position peaked at $55K in Q4 2020.
44 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2022.

Based on Ancora Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.